DGAP-News: Apricus Biosciences, San Diego Hospice and The Institute for Palliative Medicine Announce a Broad Clinical Research Program Using NexACT(R) Technology
Apricus Biosciences, Inc.
14.03.2012 15:05
—————————————————————————
SAN DIEGO, 2012-03-14 15:05 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com), San Diego Hospice (the –Hospice–) and The
Institute for Palliative Medicine today announced the signing of a clinical
development collaboration to study the use of the Company–s NexACT(r) Technology
in the hospice set
